Floatz logo

Tetanus Toxoid

Medulloblastoma Recurrent

Gary Archer Ph.D.vaccinePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Medulloblastoma Recurrent cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Medical University of Vienna
Phase 2CCC
Dfn-15
Medical University of Vienna
Phase 2CCC
Fenofibric Acid
Medical University of Vienna
Phase 2CCC
Thalidomide
Medical University of Vienna
Phase 2CCC
ETOPOSIDE
Medical University of Vienna
Phase 2CCC
Human Cmv Pp65-Lamp Mrna-Pulsed Autologous Dcs
Gary Archer Ph.D.
Phase 1CC
Gm-Csf
Gary Archer Ph.D.
Phase 1CC
G 207
M.D. Anderson Cancer Center
Phase 1CC

Same molecule, other indications

Tetanus Toxoid is also rated in:

PertussisDormant
BB
Indicative ·
65 / 100
View asset →
multiple sclerosisDormant
B
Indicative ·
63 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →